Resonate Blends, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

OID
Resonate Blends, Inc. announces a corporate name change to Apollo Biowellness, Inc. and an increase in authorized preferred stock from 10 million to 75 million shares, approved by a majority shareholder via written consent.
OID
Resonate Blends is increasing its authorized common stock from 200 million to 2 billion shares to enhance its financing and capital-raising capabilities.